O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in

A Cannizzaro1, C Verga Verga Falzacappa, M Martinelli

  • 1AFAR-Centro Ricerca S. Pietro, Fatebenefratelli Hospital, Roma, Italy.

Insights

Oxygen therapy (O(2/3)) shows promise as an anti-tumoral treatment for neuroblastoma. This study found O(2/3) inhibits neuroblastoma cell growth and induces cell cycle arrest or apoptosis, suggesting potential as a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Neuroblastoma is a significant pediatric cancer, necessitating novel therapeutic approaches.
  • Oxygen therapy, particularly hyperoxia, presents an alternative anti-tumoral strategy due to its unique physiochemical properties.
  • The efficacy of O(2/3) gas mixture as a treatment for neuroblastoma warrants investigation.

Purpose of the Study:

  • To analyze the inhibitory effect of O(2/3) treatment on human neuroblastoma cell lines (SK-N-SH and SK-N-DZ).
  • To investigate the mechanisms of O(2/3)-induced cell growth inhibition, including cell cycle perturbation and apoptosis.
  • To evaluate the potential of combining O(2/3) treatment with conventional chemotherapeutic agents.

Main Methods:

  • Treatment of SK-N-SH and SK-N-DZ neuroblastoma cell lines with O(2/3) gas mixture.
  • Analysis of cell growth inhibition, cell cycle progression (G2 arrest), and apoptosis markers (caspase 3, PARP cleavage, Bax).
  • Assessment of cyclin B1/cdk1 complex activity, Wee1, and chk1 protein levels.
  • Evaluation of combined O(2/3) and chemotherapy (Cisplatin, Etoposide, Gemcitabine) effects.

Main Results:

  • O(2/3) treatment inhibited cell growth and induced cell cycle perturbation in both neuroblastoma cell lines.
  • In SK-N-SH cells, O(2/3) caused G2 arrest with altered cyclin B1/cdk1 complex activity and increased Wee1/chk1 levels.
  • In SK-N-DZ cells, O(2/3) induced apoptosis via caspase 3 activation and PARP cleavage, with increased Bax.
  • Combined O(2/3) and chemotherapy showed enhanced inhibition in SK-N-SH cells but not significantly in SK-N-DZ cells.

Conclusions:

  • O(2/3) treatment effectively inhibits neuroblastoma cell growth through distinct mechanisms (cell cycle arrest or apoptosis) in different cell lines.
  • O(2/3) demonstrates potential as a standalone or combination therapy for neuroblastoma.
  • Further research is warranted to optimize O(2/3) therapy for neuroblastoma treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...